Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chalid Assaf

Showing results (71-80 of 124) with videos related to

Pageof 13
Sort By:
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|April 16, 2022
The optimal use of chlormethine gel for mycosis fungoides: An expert consensus from Germany, Austria and Switzerland (DACH region)Chalid Assaf, Nina Booken, Edgar Dippel, et al.
European Journal of Cancer (Oxford, England : 1990)|October 15, 2021
Dimethyl fumarate (DMF) therapy in CTCL: results from a clinical phase II studyJan P Nicolay, Jana D Albrecht, Chalid Assaf, et al.
Blood|June 9, 2016
Dimethyl fumarate restores apoptosis sensitivity and inhibits tumor growth and metastasis in CTCL by targeting NF-κBJan P Nicolay, Karin Müller-Decker, Anne Schroeder, et al.
European Journal of Cancer (Oxford, England : 1990)|October 16, 2021
Encorafenib, binimetinib plus pembrolizumab triplet therapy in patients with advanced BRAF<sup>V600</sup> mutant melanoma: safety and tolerability results from the phase I IMMU-TARGET trialLisa Zimmer, Elisabeth Livingstone, Angela Krackhardt, et al.
The British Journal of Dermatology|December 25, 2025
Radioimmunotherapy combined with antibody-drug conjugate-induced radiosensitization leads to long-term remission in mycosis fungoidesMathias Oymanns, Khaled Elsayad, Michael Daum-Marzian, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|December 26, 2024
Practical recommendations for therapy and monitoring of mogamulizumab patients in GermanyChalid Assaf, Nina Booken, Edgar Dippel, et al.
Cancers|October 16, 2024
The Landscape of Cutaneous T-Cell Lymphoma (CTCL) in the Middle East and North Africa (MENA) and the Establishment of the MENA CTCL Working GroupRasha Abdel Tawab, Jihan Rajy, Salah Abdallat, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|December 12, 2022
Zunahme des atypischen Fibroxanthoms und pleomorphen dermalen Sarkoms: eine retrospektive Analyse vier deutscher HauttumorzentrenThomas Kuntz, Julian Siebdrath, Silke C Hofmann, et al.
Dermatology (Basel, Switzerland)|September 2, 2021
Clinical Outcomes of Advanced-Stage Cutaneous Lymphoma under Low-Dose Gemcitabine Treatment: Real-Life Data from the German Cutaneous Lymphoma NetworkChristoph Blazejak, Rene Stranzenbach, Janika Gosman, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|November 28, 2022
Increase of atypical fibroxanthoma and pleomorphic dermal sarcoma: a retrospective analysis of four German skin cancer centersThomas Kuntz, Julian Siebdrath, Silke C Hofmann, et al.
Pageof 13

Showing results (71-80 of 124) with videos related to

Sort By:
Pageof 13
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|April 16, 2022
The optimal use of chlormethine gel for mycosis fungoides: An expert consensus from Germany, Austria and Switzerland (DACH region)Chalid Assaf, Nina Booken, Edgar Dippel, et al.
European Journal of Cancer (Oxford, England : 1990)|October 15, 2021
Dimethyl fumarate (DMF) therapy in CTCL: results from a clinical phase II studyJan P Nicolay, Jana D Albrecht, Chalid Assaf, et al.
Blood|June 9, 2016
Dimethyl fumarate restores apoptosis sensitivity and inhibits tumor growth and metastasis in CTCL by targeting NF-κBJan P Nicolay, Karin Müller-Decker, Anne Schroeder, et al.
European Journal of Cancer (Oxford, England : 1990)|October 16, 2021
Encorafenib, binimetinib plus pembrolizumab triplet therapy in patients with advanced BRAF<sup>V600</sup> mutant melanoma: safety and tolerability results from the phase I IMMU-TARGET trialLisa Zimmer, Elisabeth Livingstone, Angela Krackhardt, et al.
The British Journal of Dermatology|December 25, 2025
Radioimmunotherapy combined with antibody-drug conjugate-induced radiosensitization leads to long-term remission in mycosis fungoidesMathias Oymanns, Khaled Elsayad, Michael Daum-Marzian, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|December 26, 2024
Practical recommendations for therapy and monitoring of mogamulizumab patients in GermanyChalid Assaf, Nina Booken, Edgar Dippel, et al.
Cancers|October 16, 2024
The Landscape of Cutaneous T-Cell Lymphoma (CTCL) in the Middle East and North Africa (MENA) and the Establishment of the MENA CTCL Working GroupRasha Abdel Tawab, Jihan Rajy, Salah Abdallat, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|December 12, 2022
Zunahme des atypischen Fibroxanthoms und pleomorphen dermalen Sarkoms: eine retrospektive Analyse vier deutscher HauttumorzentrenThomas Kuntz, Julian Siebdrath, Silke C Hofmann, et al.
Dermatology (Basel, Switzerland)|September 2, 2021
Clinical Outcomes of Advanced-Stage Cutaneous Lymphoma under Low-Dose Gemcitabine Treatment: Real-Life Data from the German Cutaneous Lymphoma NetworkChristoph Blazejak, Rene Stranzenbach, Janika Gosman, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|November 28, 2022
Increase of atypical fibroxanthoma and pleomorphic dermal sarcoma: a retrospective analysis of four German skin cancer centersThomas Kuntz, Julian Siebdrath, Silke C Hofmann, et al.
Pageof 13